Literature DB >> 8034096

Cryopreservation of microsurgically extracted ductal sperm: pentoxifylline enhancement of motility.

J P Buch1, K A Philips, T F Kolon.   

Abstract

Microscopically extracted ductal sperm can be successfully cryopreserved using motility as the outcomes measure. The optimal regimen for cryopreservation of microscopically extracted ductal sperm awaits further determination. Pentoxifylline treatment improves initial post-thaw motility of cryopreserved microscopically extracted ductal sperm. The clinical efficacy of this practice awaits further determination. However, the best potential use for cryopreserved microscopically extracted ductal sperm may be IVF with subzonal or intracytoplasmic microinjection. If intracytoplasmic sperm injection becomes more widely available, then enhancement of motility with pentoxifylline may not be necessary. This approach allows for potential fertility insurance at the time of microsurgical bypass of obstruction, and it may preclude, the need for the andrologic surgeon to accurately time his sperm retrieval procedures with IVF. The latter potential advantage would significantly aid current logistical difficulties in the operating room.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034096     DOI: 10.1016/s0015-0282(16)56902-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Pregnancy achieved by intracytoplasmic injection of cryopreserved epididymal sperm microsurgically aspirated from a man with long-term vasectomy.

Authors:  Y M Chan; M I Abuzeid; M A Sasy; M R Beer
Journal:  J Assist Reprod Genet       Date:  1995-05       Impact factor: 3.412

2.  Pentoxifylline initiates motility in spontaneously immotile epididymal and testicular spermatozoa and allows normal fertilization, pregnancy, and birth after intracytoplasmic sperm injection.

Authors:  P Terriou; E Hans; C Giorgetti; J L Spach; J Salzmann; V Urrutia; R Roulier
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.